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ABSTRACT
Objectives: To explore and describe the value general
practitioner (GPs) attribute to medical guidelines when
they are applied to patients with multimorbidity, and to
describe which benefits GPs experience from guideline
adherence in these patients. Also, we aimed to identify
limitations from guideline adherence in patients with
multimorbidity, as perceived by GPs, and to describe their
empirical solutions to manage these obstacles.
Design: Focus group study with purposive sampling of
participants. Focus groups were guided by an experienced
moderator who used an interview guide. Interviews were
transcribed verbatim. Data analysis was performed by two
researchers using the constant comparison analysis
technique and field notes were used in the analysis. Data
collection proceeded until saturation was reached.
Setting: Primary care, eastern part of The Netherlands.
Participants: Dutch GPs, heterogeneous in age, sex and
academic involvement.
Results: 25 GPs participated in five focus groups. GPs
valued the guidance that guidelines provide, but
experienced shortcomings when they were applied to
patients with multimorbidity. Taking these patients’
personal circumstances into account was regarded as
important, but it was impeded by a consistent focus on
guideline adherence. Preventative measures were
considered less appropriate in (elderly) patients with
multimorbidity. Moreover, the applicability of guidelines in
patients with multimorbidity was questioned. GPs’
extensive practical experience with managing
multimorbidity resulted in several empirical solutions, for
example, using their ‘common sense’ to respond to the
perceived shortcomings.
Conclusions: GPs applying guidelines for patients with
multimorbidity integrate patient-specific factors in their
medical decisions, aiming for patient-centred solutions.
Such integration of clinical experience and best evidence
is required to practise evidence-based medicine. More
flexibility in pay-for-performance systems is needed to
facilitate this integration. Several improvements in
guideline reporting are necessary to enhance the
applicability of guidelines in patients with multimorbidity.
INTRODUCTION
Multimorbidity, the existence of multiple
chronic conditions within a particular
patient,1 is very common.2–5 It has a substan-
tial impact on healthcare utilisation and
costs5–7 and on patient outcomes,7 8 putting
great demands on global healthcare. The
care of patients with multimorbidity is
complex, requiring coordinated care, man-
agement of chronic diseases and medication,
which may be challenging for practitioners
having only short consultations available.9
Evidence-based medicine and guidelines
have improved the quality of healthcare
through better diagnostic and therapeutic
treatment decisions. However, their applica-
tion can be problematic when a patient has
more than one disease, as guidelines are gen-
erally written for single diseases, with limited
suitability for multimorbidity.10–12 A focus on
single disease guidelines brings the risk of
‘siloing of care’ for patients with multimor-
bidity.13 14 National Institute for Health and
Care Excellence is preparing a guideline on
Strengths and limitations of this study
▪ This focus group study provided new insights
into the value general practitioner (GPs) attribute
to guidelines when they are applied to patients
with multimorbidity, and their empirical solutions
to manage perceived obstacles from inappropri-
ate guideline adherence in these patients.
▪ Data were collected from focus groups that were
part of a larger research project on multimorbid-
ity, to explore GPs’ aims and priority setting in
the care they deliver to patients with
multimorbidity.
▪ Focus group discussions were held in the
context of Dutch healthcare, not allowing gener-
alisations to the primary care context in general,
but the resemblance of the GP sample to the
Dutch professional GP group does increase the
transferability of our findings.
▪ GPs in countries with a healthcare system com-
parable to that in The Netherlands may experi-
ence similar problems in application of
guidelines in patients with multimorbidity.
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the clinical assessment and management of multimor-
bidity.15 The wide spectrum of multimorbidity is a prac-
tical limitation to develop guidelines for disease
combinations. However, guidance in how to combine or
prioritise guideline recommendations or when to stop
recommended treatments could improve the care of
patients with multimorbidity, but is missing in current
guidelines.14 16 17
Given the high prevalence of multimorbidity, all clini-
cians may struggle with guideline application in patients
with multimorbidity. However, generalists who provide
care to patients with any disease type without prioritising
one disease over another beforehand may speciﬁcally
have well-formulated ideas on this issue. It is to be
expected that general practitioners (GPs) would have
extensive experience in managing multimorbidity
despite a gap in evidence-based guidance, and have
developed practical solutions to deal with this gap. Many
papers investigating practitioners’ experiences with mul-
timorbidity management, however, had a focus on the
challenges they faced in the care of patients with multi-
morbidity, and not on their experiences with or solu-
tions for handling guidelines in these patients.18
In The Netherlands, the Dutch College of General
Practitioners (DCGP, Nederlands Huisartsen Genootschap
(NHG)) has produced evidence-based guidelines cover-
ing 70–80% of the conditions presented in primary care.
GPs play a leading role in the development and critical
appraisal of these guidelines, of which 92 are currently
available, and of which approximately one-third con-
cerns (potentially) chronic conditions.19 DCGP guide-
lines cover diseases, symptoms and risk factors, and are
established in a team composed of GPs, both with and
without speciﬁc expertise concerning the topic, and
representatives of other professional groups. Dutch GPs
receive capitation payment, as well as a limited add-
itional payment for the management of chronic diseases
such as diabetes and chronic obstructive pulmonary
disease when quality indicators are met. The DCGPs’
guidelines are a main source of reference of diagnostic
and therapeutic quality indicators.
Our objective was to explore and describe the value
GPs attribute to medical guidelines when they are
applied to patients with multimorbidity, and to describe
which beneﬁts GPs experience from guideline adher-
ence in these patients. Also, we aimed to identify limita-
tions from guideline adherence in patients with
multimorbidity, as perceived by GPs, and to describe
their empirical solutions to manage these obstacles.
METHOD
Study design and participants
As part of a larger research project on multimorbidity,
focus group interviews with GPs have been held to
explore GPs’ aims and priority setting in the care they
deliver to patients with multimorbidity, and the factors
that facilitate and impede this.
We found that their main aim was to apply a patient-
centred approach.20 It was anticipated that the role of
guidelines as a potential facilitator or barrier of the care
delivery to patients with multimorbidity might be men-
tioned. In the iterative qualitative process, in which data
collection and analysis alternate, the insight grew that
discussions on the role of guidelines, applied to patients
with multimorbidity, provided important information
meriting deeper exploration on itself. This resulted in
formulating the current, additional research question:
exploring the value GPs attribute to guidelines for multi-
morbidity. This topic came up spontaneously in the ﬁrst
focus groups and it was probed in the following group
interviews if it did not arise spontaneously again. The
original interview guide was not altered. When the role
of guidelines had not yet been discussed spontaneously
after discussing which factors were perceived as imped-
ing factors in the management of multimorbidity, parti-
cipants were asked if they perceived guidelines as an
impeding or facilitating factor in this respect. A separate
qualitative analysis was performed on the same qualita-
tive data considering the current research question. In a
purposive sampling strategy, GPs from the academic
network of the Radboud University Medical Center and
from the personal network of the research team
members were invited to participate, ‘to gain more
insight into GPs’ experiences with the care for patients
with multimorbidity’. They were contacted by mail and
telephone. The location of their practices covered a
40-mile area around the city Nijmegen, in the eastern
part of The Netherlands. Heterogeneity in character-
istics such as age, sex, academic involvement and urban-
isation was ensured. After having conducted four focus
groups, in all of which at least one GP with an academic
afﬁliation (GP trainer or researcher) participated, we
decided to organise a ﬁfth focus group with only non-
academic GPs, since we anticipated that an academic
afﬁliation might inﬂuence their ideas regarding the
initial question and the current research question. All
GPs consented to participate. Anonymity and conﬁdenti-
ality were ensured. According to Dutch legislation, inter-
viewing healthcare professionals regarding their
professional beliefs does not need approval of an exter-
nal ethics committee. Participants were offered a gift
voucher and compensation of travel expenses in appreci-
ation of their efforts.
The focus groups were held between September 2010
and March 2011 and took place at the Radboud
University Medical Center. One focus group was con-
ducted in the practice of a research team member since
this resulted in a shorter travel distance for the partici-
pating GPs. Twenty-ﬁve GPs participated in 5 focus
groups, each group containing 4–6 participants. Table 1
shows their characteristics. Some participating GPs knew
the moderator, the observer or other participating GPs
in their focus group, whereas others did not.
Focus groups can be regarded as appropriate qualita-
tive methods, since the group process may help to
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explore and clarify views of participants, and facilitates
different forms of communication, which could help in
generating new insights.21
Focus group interviews and data collection
A GP senior researcher with extensive experience in
qualitative research moderated the focus groups, using
an interview guide (available from the authors on
request). One researcher observed all group interviews
and paid special attention to non-verbal communication.
The observer’s ﬁeld notes were used during analysis, for
example, to identify non-verbally expressed (dis)agree-
ment with other comments. The interviews were audio-
taped and transcribed verbatim by a medical student.
Analysis
The constant comparative analysis technique was applied
by two researchers to analyse the data for the current
aims.22 Disagreement was resolved by discussion or con-
sultation with other researchers. The transcripts were
read intensively. Open coding was ﬁrst applied to con-
ceptualise the data. This was followed by axial coding,
where codes were clustered, side issues were distin-
guished from essentials and initial concepts were
checked against newly collected data. Selective coding
was applied in the ﬁnal analysis stage to integrate data
after initial fragmentation. Invalidating examples were
sought. Data collection proceeded until saturation was
reached concerning the current research question,
which was the case after the ﬁfth focus group. At this
stage, no new insights were gained regarding GPs’ evalu-
ation of guidelines applied to patients with multimorbid-
ity. ATLAS.ti (V.7, Berlin, Germany) supported the
analysis. Citations illustrating important points discussed
needed translation, which was performed by a native
English speaker translator familiar with qualitative
research in healthcare. In this way, potential loss of
reﬁnement in translated citations was reduced as much
as possible.
RESULTS
Overview of the results
GPs commented on the value of guidelines they per-
ceived when applied to patients with multimorbidity,
and on beneﬁts from guideline adherence. They also
described potential limitations from guideline adher-
ence in these patients, which have led to several empir-
ical solutions to counteract these. A point-by-point
description of these discussed items is outlined below.
Value of guidelines applied to patients with
multimorbidity
GPs valued evidence-based guidelines in general, and
felt that their wide implementation had brought clear
improvements to the quality of general practice. They
especially perceived guidelines as useful in the case of
younger, relatively healthy patients, particularly if they
suffered just from the disease described in the guideline.
Most GPs followed guidelines also for the younger and
‘healthier’ patients with multimorbidity, particularly if
their multiple diseases had similar therapeutic
approaches. In these cases of multimorbidity, guidelines
provided guidance to medical decision-making, for
example, prescription of medication (A-B). Online sup-
plemental ﬁle 1 shows all quotations.
Reduction of patients’ perceived symptoms (pain, short-
ness of breath) was an important reason for GPs to adhere
to guidelines in patients with multimorbidity (C, D).
Guideline adherence also helped in working transpar-
ently, enabling comparison and quality control between
GPs. GPs did express a need for guidelines despite the
difﬁculties in translating these into the practical care for
patients with multimorbidity (E, F). GPs stated that it
would be unrealistic that guidelines should specify for
any possible disease combinations, but would feel better
supported in the care for patients with multimorbidity
when guidelines gave more details for diagnostic, treat-
ment and management priorities.
Limitations from guideline adherence in patients with
multimorbidity
Limited usefulness of guideline adherence in multimorbidity
There was agreement that guidelines were less useful for
elderly patients and ‘complex cases’ of multimorbidity.
GPs commented that guidelines were essentially not
Table 1 Characteristics of participating general
practitioners (GPs)* (total number: 25)
n (%)
Sex
Male 18 (72)
Female 7 (28)
Practice type
Single† 4 (16)
Duo or group 21 (84)
Urbanisation
Rural area 2 (8)
Urbanised rural area 16 (64)
Urban area 7 (28)
GP trainer‡
At present 11 (44)
In the past 1 (4)
Never 13 (52)
Researcher
Yes 5 (20)
No 20 (80)
Mean age, years (range) 50 (31–63)
Mean experience as GP, years (range) 20 (2–36)
*Sex, age, practice type and urbanisation were similarly distributed
among participants in our sample as compared to the Dutch
professional group of GPs.24
†Count of GPs settled solitary in a practice, that is, without
employment of or professional collaboration with other GPs.
‡Trainer at the Nijmegen residency training programme, a
qualification needed to supervise a GP trainee.
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designed for these complex patients (G, H) and felt that
in these cases implementation was not as straightforward
as in younger patients (I).
A component of this limitation of guidelines was the
issue of ‘prevention’. GPs felt that adherence to
guideline-recommended preventative measures was less
appropriate in the case of older patients with multimor-
bidity and patients with a limited life expectancy. This
was more pronounced if these measures were accompan-
ied by side effects. They also questioned whether similar
beneﬁts could be expected from preventative measures
as for younger or healthier patients. When GPs felt less
convinced of the advantages of prevention, they
would put less emphasis on this topic in the consult-
ation. A sense of acceptance of limited therapeutic or
preventative beneﬁts was expressed if it concerned older
patients. ( J-N).
Guideline adherence conflicts with a patient-centred
approach
Despite the need for guidelines, GPs often saw good
reasons to ignore guideline recommendations in individ-
ual circumstances or to omit treatments in patients with
multimorbidity. Consistent guideline adherence was per-
ceived as an impediment to deliver individualised,
patient-centred healthcare to patients with multimorbid-
ity, which emerged as GPs’ major objective in their care
(described in detail in our previous paper20). This came
forward in their inclusion of patients’ preferences and
circumstances in their management decisions, even
when this meant ignoring guideline recommendations
(O). Some GPs expressed this explicitly while many
agreed with such comments.
It was considered impossible to exhaustively grasp the
complexity within guidelines that inevitably comes along
with multimorbidity (P).
A perceived risk of working too much ‘guideline-
driven’ is that items addressed in the guidelines will be
automatically prioritised over patients’ other important
health problems (Q).
Concerns about the applicability of guidelines in
multimorbidity
Scepticism was articulated on the applicability of
evidence-based guidelines in patients with multimorbid-
ity. Concerns were expressed that patients included in
research and their speciﬁc circumstances are not
comparable to patients with multimorbidity. Guideline
recommendations following research results are
not simply generalisable to patients with multimorbidity
(R, S).
Also, GPs commented that combining therapeutic
regimens, originating from evidence-based guidelines
written for single diseases, does not lead to an evidence-
based combination for patients with multimorbidity.
Guidelines can be conﬂicting, and often it is unclear
how they relate to one another, which impedes using
several guidelines for one particular patient (T, U).
Empirical solutions
The disadvantages GPs perceived from guideline appli-
cation to patients with multimorbidity resulted in several
practical solutions, enabling them to provide continuous
healthcare to these patients. This paragraph summarises
the empirical solutions mentioned.
From their experience, GPs expressed a need to rely
on their ‘common sense’—a source of ‘knowledge’ that
may complement the limitations of guideline application
in multimorbidity. This implied making patient-centred
decisions, accounting for the personal circumstances of
patients with multimorbidity (V). However, relying on
one’s ‘common sense’ only was not considered
acceptable anymore in the current era. Guideline adher-
ence and applying ‘common sense’ needed to be in
balance (W).
One GP described that an authorised guideline is not
the only source providing support to GPs in the difﬁcult
decisions they need to make in patients with multimor-
bidity. He suggested that regular refresher courses on
complex topics could provide more knowledge and
insight leading to guidance in a different way (X).
Additionally, improvements could be made in guide-
line reporting, to increase their value for patients with
multimorbidity. A GP proposed having a ranking of
importance made in recommended (preventative) mea-
sures for patients with multimorbidity, considering the
seriousness of adverse results if they are not adhered to
(Y). The same GP proposed, with agreement of the
other GPs in his group, that guidelines should more
explicitly comment on their external validity (Z). This
could provide support to GPs not to adhere to guidelines
for speciﬁed reasons or in speciﬁc situations—creating
valid reasons to make patient-centred decisions by apply-
ing their ‘common sense’.
Another GP tried to explain to his patients the evi-
dence underlying guideline recommendations. In a con-
versation on how to translate guidelines into personal
treatment choices, he let these well-informed patients’
opinions inﬂuence decisions on whether or not to start
new treatments—again coming to a patient-centred solu-
tion (AA).
Finally, permission to exclude patients with multimor-
bidity from regular pay-for-performance systems could
reduce the burden of imposed but inappropriate guide-
line adherence, and improve the quality of care deliv-
ered to patients with multimorbidity (BB, CC). In those
focus groups where the issue of pay-for-performance was
discussed, GPs agreed that guideline-derived incentives
for patients with multimorbidity were undesirable and
inappropriate (DD).
DISCUSSION
Summary
In this paper, we explored and described how GPs value
evidence-based guideline application in patients with
multimorbidity, that is, patients in whom they had
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several potential guidelines to follow at the same time.
GPs treasure the availability of guidelines in general, but
at the same time expressed that guidelines do not cover
the requirements needed to deliver complex care to
patients with multimorbidity. They do not give sufﬁcient
opportunities to provide the desired individualised
approach in multimorbidity, which may be considered as
more important than adherence to the guidelines.
Recommendations from single disease guidelines are not
simply generalisable to patients with multimorbidity.
When GPs apply guidelines for patients with multimor-
bidity, they incorporate patients’ speciﬁc circumstances.
Guideline-supported care to patients with multimorbidity
can therefore be regarded as a good illustration of the
use of the core values of primary care.23 This paper pro-
vides a new insight that, from their practical experience
with patients with multimorbidity, GPs apply empirical
solutions, such as balancing guideline recommendations
with their ‘common sense’ and a patient-centred
approach, to counteract guidelines’ pitfalls.
Strengths and limitations
This study was performed by applying robust qualitative
methods. Focus groups were guided by an experienced
moderator with familiarity with the subject discussed.
Participating GPs had been invited using a purposive
sampling strategy. It is possible that GPs with a special
interest in complex care, such as care for patients with
multimorbidity, were more inclined to attend a focus
group session than GPs without such an interest. This
might have increased the vivacity of discussions, but par-
ticipants were not selected on this criterion. Data collec-
tion proceeded until saturation was reached. The entire
analysis was performed by two researchers, using the
constant comparative analysis technique, which is an
appropriate technique in qualitative research if new
theory is to be generated.
Focus group discussions were held in Dutch and in
the context of Dutch healthcare, thus providing views of
participating Dutch GPs. The results do not allow gener-
alisations to the primary care context in general.
However, the resemblance of our GP sample to the
Dutch professional GP group24 does increase the trans-
ferability of our ﬁndings.25 GPs in countries with a
healthcare system comparable to that in The
Netherlands may experience similar problems from
guideline application in patients with multimorbidity,
and their practical answers to such puzzles might show
similarities to the empirical solutions described in the
current study. Future research should elaborate this.
Some time span existed between data collection and the
writing of this paper, because it had not been planned
originally to produce a separate paper speciﬁcally focus-
ing on the role of guidelines applied to patients with
multimorbidity. In the mean time, the number of new
publications on this theme was limited. It seems unlikely
that this ‘publication delay’ inﬂuenced our ﬁndings sig-
niﬁcantly. The role attributed to comorbidity in new
(Dutch) primary care guidelines was not obviously dif-
ferent than before our data collection.
Our research question produced new insight into a
research ﬁeld without much preceding literature. This
originality provides the major strength of our work.
Fitting the iterative nature of qualitative research, the
idea to analyse the data regarding the current research
question arose gradually. Although this theme was an
explicit subject of discussions, participants were not
made aware of it as an additional research question
beforehand. Had this been the case, participants might
have been overthinking the speciﬁc issue of guideline
application in patients with multimorbidity consciously,
which could have resulted in the expression of beliefs
that remained unrevealed now. We ﬁnd it unlikely that
with such a scenario participants would have expressed
clearly deviant ideas from the ideas they expressed here.
However, it is not possible to establish if and to what
extent our results would have been expanded or altered
were this research question announced explicitly.
On most of the subjects discussed, we found no obvious
difference between beliefs expressed by GPs with different
characteristics, with two exceptions. Discussions on the
applicability of guidelines in multimorbidity, and about
the empirical solutions applied to overcome the guide-
lines’ disadvantages, were mainly brought up by GPs with
an academic afﬁliation. GPs without academic involvement
did not express opposing views but accepted these beliefs
and agreed with them in general. As a consequence, we
conclude that there were no contrasting beliefs between
‘academic’ and ‘non-academic’ GPs, but that academic
GPs were better able to articulate the tensions between
patient-centred and guideline-directed care. This might be
caused by a greater familiarity of researchers with the way
guidelines are realised, and GP trainers’ custom to reﬂect
on their own practice as they do in the GP residency pro-
gramme, which makes them ‘trained’ in expressing their
beliefs. This may have helped in gaining valuable insights
from these participants.
It came as some surprise that the collaboration with
specialists did not feature strongly in the discussions.
This may be due to the structure of this study, focused
on the role of guidelines, and the fact that GPs in The
Netherlands identify strongly with the DCGP guidelines
as ‘their own’.19 Our previous study, describing GPs’ con-
siderations and main aims in multimorbidity manage-
ment, did include GPs’ views on cooperation with
specialists.20
Comparison with the existing literature
The ﬁndings of this study help to reﬂect on the
adequacy of ‘guideline-based’ modern medicine from
the GP perspective. Evidence-based guidelines are per-
ceived as useful in general, but several shortcomings are
experienced in patients with multimorbidity. Important
problems arise from discrepancies between recommen-
dations based on single-disease guidelines, and that what
is perceived by GPs as serving a particular patient with
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multimorbidity best. From a patient-centred work style,
GPs try to achieve shared decision-making; they individu-
alise treatments and may deliberately omit speciﬁc treat-
ments. In the setting of a continuous clinical
relationship, knowing the context of the patient informs
intuitive judgements.26 This ‘knowing of the particular’ is
at the heart of general practice, but may be seen as con-
trasting with the principles of biomedical science, where
it is explained what patients have in common and ignores
where they differ.27 However, the practice of evidence-
based medicine requires integration of individual clinical
experience with the best available external clinical
evidence: good doctors need to rely on both.28–30 This
integration is exactly what was expressed by our participat-
ing GPs as an empirical solution to deal with the discrep-
ancy between guideline adherence and providing optimal
care in patients with multimorbidity.
To the best of our knowledge, no previous papers spe-
ciﬁcally analysed the value of guidelines for patients with
multimorbidity as it is perceived by practitioners who
use them in clinical practice. A few previous papers
describing how GPs deal with multimorbidity reported
brieﬂy on the value of medical guidelines in this respect.
Qualitative data have been synthesised by Sinnott et al,18
concluding that mixed feelings exist on the clinical
utility of guidelines.
Some previous studies demonstrated guidelines’
limited suitability in patients with multimorbidity: they
showed that the frequency and consistency of recommen-
dations accounting for patients’ comorbidity are low, and
that they provide limited guidance in making treatment
priorities.10–12 These constraints, which were identiﬁed in
literature reviews and on merely theoretic grounds, have
now been exempliﬁed by our qualitative data.
Two original studies, focusing on GPs’ perspectives on
care for older patients with multimorbidity, produced
results that show similarities to our ﬁndings. Fried et al
described variable beliefs regarding beneﬁts and harms
of guideline-directed care among their participants.
Those who expressed concerns did so regarding the
limited external validity, and the adverse events that may
be caused by applying multiple guidelines. Additionally,
guidelines’ target outcomes may not be most relevant
for patients with multimorbidity.31 In a Dutch focus
group study exploring ‘GPs’ feelings on deprescribing
medication’, participants also distinguished medication
prescribed for symptomatic conditions and preventative
medication. They experienced a lack of information
regarding risks and beneﬁts of preventative medication
in patients with multimorbidity, and felt compelled to
prescribe by the present guideline.32
The difﬁculties experienced in practice by our
participating GPs led to suggestions of how to make
evidence-based guidelines more viable in patients with
multimorbidity—a necessary step, since guidelines are
indispensable in the current era, as was conﬁrmed by the
participants. Other papers describing barriers made
some similar suggestions, for example, accounting for the
patient’s context,10 30 31 33 focusing on generic instead of
disease-speciﬁc outcomes,34 35 providing guidance in
prioritising guideline recommendations16 17 32 and
improving the external validity of clinical trials and guide-
line recommendations.16 36 In addition, it has been
recommended to include more elderly people and
patients with comorbidity in future studies,16 17 and to
apply more cross-referencing between existing guidelines,
in order to enhance guidelines’ usefulness in patients
with multimorbidity.17 An innovative possibility is to apply
the concept of ‘pay-off time’, predicting if a patient with
limited life expectancy is likely to beneﬁt from adherence
to a particular guideline, by calculating the minimum
time until its cumulative beneﬁts exceed its cumulative
harms.37 These suggestions all address very well the
guidelines’ limitations mentioned by our participants.
‘Complexity theory’ has been used to implement inter-
ventions in the primary care setting, and yielded sus-
tained effects in individualising the structure and
processes of care towards individual values.38 39 This
reﬂects the challenges GPs reported in our study to
address the needs of patients. Since their approach
worked in different participating practices, this would
make ‘complexity theory’ a valuable approach to incorp-
orate in the organisation culture of care of patients with
multiple health problems.
Reformulating ‘quality of care’ in patients with multi-
morbidity and adapting pay-for-performance systems
accordingly is a merely practical need to better address
multimorbidity. It challenges current systems in which
payment is based on adherence to guideline-based
recommendations. This suggestion, raised by partici-
pants in our study, ﬁnds support in the literature.31 40
A new proposal from this study is to make more use of
post-academic trainings focused on multimorbidity. This
reduces the need to rely on guidelines only as a resource
providing guidance in difﬁcult treatment decisions.
Implications for research and/or practice
To conclude, inconsiderate adherence to guidelines is
undesirable in the care of patients with multimorbidity,
and would come at the risk of losing ‘the art of medi-
cine’. Nevertheless, evidence-based guidelines are indis-
pensable components of modern medicine. Several
suggestions have now been summarised on how to
improve the applicability of guidelines in patients with
multimorbidity, for example, increasing and better
reporting of the external validity in future research, and
prioritising guideline recommendations. Patient-centred
care provision demands adjusting professional tasks to a
speciﬁc patient’s needs. This requires practitioners’
autonomy to deviate from guideline recommendations
when appropriate, without negative ﬁnancial conse-
quences, especially in the case of multimorbidity.
Facilitating such ﬂexibility could help to accomplish the
provision of patient-centred care to patients with multi-
morbidity, a much needed and desired pursuit by
patients as well as GPs.
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